456P ercutaneous coronary intervention (PCI) for ST-segmentelevation myocardial infarction and an early invasive strategy, which may include PCI, for non-ST-segmentelevation acute coronary syndrome (NSTEACS) are associated with improved clinical outcomes. 1,2 Such patients receive multiple adjunctive antithrombotic therapies, which increase bleeding risk. In acute coronary syndromes, bleeding is a significant predictor of morbidity and mortality. 3 Although access-site complications represent an important source of bleeding, especially when transfemoral access (TFA) is used, 4-6 in NSTEACS, access-site bleeding accounts for a smaller proportion of bleeding events compared with Background-Compared with transfemoral access, transradial access (TRA) for percutaneous coronary intervention is associated with reduced risk of bleeding and vascular complications. Studies suggest that TRA may reduce mortality in patients with ST-segment-elevation myocardial infarction. However, there are few data on the effect of TRA on mortality, specifically, in patients with non-ST-segment-elevation myocardial infarction.